Kwong YL - Search Results

1

Pseudonephrotic syndrome caused by lysozymuria.

Mok CC, Tam SC, Kwong YL. Mok CC, et al. Among authors: kwong yl. Ann Intern Med. 1994 Nov 15;121(10):818. doi: 10.7326/0003-4819-121-10-199411150-00020. Ann Intern Med. 1994. PMID: 7944068 No abstract available.

2

Secondary acute myeloid leukaemia with 7q- complicating azathioprine treatment for rheumatoid arthritis.

Mok CC, Kwong YL, Lau CS. Mok CC, et al. Among authors: kwong yl. Ann Rheum Dis. 1995 Feb;54(2):155-6. doi: 10.1136/ard.54.2.155-b. Ann Rheum Dis. 1995. PMID: 7702408 Free PMC article. No abstract available.

3

Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis.

Au WY, Fong BM, Tam S, Kwong YL. Au WY, et al. Among authors: kwong yl. Ann Hematol. 2013 Mar;92(3):417-8. doi: 10.1007/s00277-012-1576-1. Epub 2012 Sep 30. Ann Hematol. 2013. PMID: 23053177 Free PMC article. No abstract available.

4

Hypertrichosis due to porphyria cutanea tarda associated with blastic transformation of myelofibrosis.

Au WY, Tam SC, Ho KM, Lam CW, Kwong YL. Au WY, et al. Among authors: kwong yl. Br J Dermatol. 1999 Nov;141(5):932. doi: 10.1046/j.1365-2133.1999.03175.x. Br J Dermatol. 1999. PMID: 10583184 No abstract available.

5

Oral arsenic trioxide therapy for acute promyelocytic leukemia before and after liver transplantation for hepatitis B virus-related liver failure.

Au WY, Liu CL, Tam S, Fong BM, Shek TW, Hui CK, Kwong YL. Au WY, et al. Among authors: kwong yl. Ann Hematol. 2007 Oct;86(10):771-2. doi: 10.1007/s00277-007-0318-2. Epub 2007 Jun 15. Ann Hematol. 2007. PMID: 17571262 No abstract available.

6

Entry of elemental arsenic into the central nervous system in patients with acute promyelocytic leukemia during arsenic trioxide treatment.

Au WY, Tam S, Kwong YL. Au WY, et al. Among authors: kwong yl. Leuk Res. 2008 Feb;32(2):357-8. doi: 10.1016/j.leukres.2007.06.005. Epub 2007 Jul 26. Leuk Res. 2008. PMID: 17662385 No abstract available.

7

Oral arsenic treatment of leukemia and the risk of porphyria.

Au WY, Tam S, Fong BM, Kwong YL. Au WY, et al. Among authors: kwong yl. Leuk Res. 2009 Apr;33(4):598-600. doi: 10.1016/j.leukres.2008.08.016. Epub 2008 Oct 1. Leuk Res. 2009. PMID: 18829106 No abstract available.

8

Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.

Au WY, Tam S, Fong BM, Kwong YL. Au WY, et al. Among authors: kwong yl. Blood. 2008 Nov 1;112(9):3587-90. doi: 10.1182/blood-2008-06-161000. Epub 2008 Aug 14. Blood. 2008. PMID: 18703707 Free article.

9

Elemental arsenic entered the cerebrospinal fluid during oral arsenic trioxide treatment of meningeal relapse of acute promyelocytic leukemia.

Au WY, Tam S, Fong BM, Kwong YL. Au WY, et al. Among authors: kwong yl. Blood. 2006 Apr 1;107(7):3012-3. doi: 10.1182/blood-2005-10-4175. Blood. 2006. PMID: 16554490 Free article. No abstract available.

10

Diagnosis of familial amyloidotic polyneuropathy by bone marrow biopsy.

Wong KF, Tam S, Kwong YL. Wong KF, et al. Among authors: kwong yl. Br J Haematol. 2007 Nov;139(4):517. doi: 10.1111/j.1365-2141.2007.06800.x. Epub 2007 Oct 3. Br J Haematol. 2007. PMID: 17916106 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

725 results

Search Page